Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
about
The perils of PCR: can we accurately 'correct' antimalarial trials?Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytbThe Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.Rapid identification of chloroquine and atovaquone drug resistance in Plasmodium falciparum using high-resolution melt polymerase chain reactionPlasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b geneEmergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsNovel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in NigeriaArtemether-lumefantrine compared to atovaquone-proguanil as a treatment for uncomplicated Plasmodium falciparum malaria in travelers.Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.Implementation of a novel PCR based method for detecting malaria parasites from naturally infected mosquitoes in Papua New Guinea.Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to ThailandAntimalarial drugs: modes of action and mechanisms of parasite resistance.Therapy of vector-borne protozoan infections in nonendemic settings.Clinical implications of a gradual dormancy concept in malaria.Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance.Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.The selective outpatient treatment of adults with imported falciparum malaria: a prospective cohort study.Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.Antimalaria drug resistance: the mono-combi-counterfeit triangle.
P2860
Q24615919-DC5ABA90-2668-4896-BC2D-AD1B09B701E4Q28550420-A80D1C5F-B3B7-47E5-84E7-481746BE7A48Q30253026-874E946A-F80D-4756-B86B-2D283CF53D12Q33895143-903DA8BA-37FB-4B7F-A8EB-44DFBA145718Q33898569-710B7C18-1CB9-4837-AFB7-0095E5CF8243Q34058304-AAE6F80C-01E0-4D5F-93ED-E72AE6E4F760Q34802106-69A20399-1D45-4AED-B33C-98E86C6185CAQ35140545-6F54F4BA-D850-4619-B358-5996AC2A55F7Q35745986-364F0172-FF5B-485C-A476-3A11315F56A3Q36644858-1D0D0C1D-8630-4B24-9D9B-F430453F84CFQ37274739-DABC1C6E-52B2-4D16-821D-979CA3F74A08Q37312808-E468F382-D5B2-4D70-897D-D8CBF4F47448Q37358872-1C39A0E5-99A7-4196-B7A4-E70548F8655AQ37820670-3C4BC5BB-8D10-49E2-8DAE-60F6CC8FAF11Q37879203-FF774F44-DBA8-4AE7-A2F6-F3680F90D99FQ38808471-30FEC4D3-2CC9-43E2-90B9-08DBB087D2DCQ39605132-A8E49795-B39A-405F-A64F-7EB09C7EAED4Q40106428-F02FEFE0-6172-4046-A204-2E2C27C7DA13Q40888299-6CC3AC7C-3FB8-4DBC-8D18-2F73C1F2097FQ41547525-B49031B6-29C4-4C5A-A425-8ED185DCB2BAQ46705598-C00DC929-0C06-4704-B79B-B3EDC9F06C2BQ47918596-C81CBE03-C43D-4871-90AA-EAB52ECC2403
P2860
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@ast
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en-gb
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@nl
type
label
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@ast
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en-gb
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@nl
prefLabel
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@ast
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en-gb
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Mutations in the Plasmodium fa ...... ated with atovaquone-proguanil
@en
P2093
Geoffrey Pasvol
John L Klein
Martina Burke
Matt Laundy
Nicholas Price
Peter L Chiodini
Quinton L Fivelman
P2860
P2888
P3181
P356
10.1186/1475-2875-7-240
P407
P577
2008-01-01T00:00:00Z
P5875
P6179
1025365550